Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Inflammation in stroke: the role of cholinergic, purinergic and glutamatergic signaling.

Martín A, Domercq M, Matute C.

Ther Adv Neurol Disord. 2018 May 4;11:1756286418774267. doi: 10.1177/1756286418774267. eCollection 2018. Review.

2.

1-42 triggers the generation of a retrograde signaling complex from sentinel mRNAs in axons.

Walker CA, Randolph LK, Matute C, Alberdi E, Baleriola J, Hengst U.

EMBO Rep. 2018 May 14. pii: e45435. doi: 10.15252/embr.201745435. [Epub ahead of print]

PMID:
29759981
3.

Gradually Transformed: Parry-Romberg Syndrome.

Matute CF, Matute FJ, Cardona D, Federman DG.

Am J Med. 2018 Mar 26. pii: S0002-9343(18)30216-X. doi: 10.1016/j.amjmed.2018.02.020. [Epub ahead of print] No abstract available.

PMID:
29596787
4.

Microglial immune response is impaired against the neurotropic fungus Lomentospora prolificans.

Pellon A, Ramirez-Garcia A, Guruceaga X, Zabala A, Buldain I, Antoran A, Anguita J, Rementeria A, Matute C, Hernando FL.

Cell Microbiol. 2018 Mar 26:e12847. doi: 10.1111/cmi.12847. [Epub ahead of print]

PMID:
29582549
5.

In vivo imaging of Α7 nicotinic receptors as a novel method to monitor neuroinflammation after cerebral ischemia.

Colás L, Domercq M, Ramos-Cabrer P, Palma A, Gómez-Vallejo V, Padro D, Plaza-García S, Pulagam KR, Higuchi M, Matute C, Llop J, Martín A.

Glia. 2018 Mar 12. doi: 10.1002/glia.23326. [Epub ahead of print]

PMID:
29528142
6.
7.

Building Bridges through Science.

Lissek T, Adams M, Adelman J, Ahissar E, Akaaboune M, Akil H, al'Absi M, Arain F, Arango-Lasprilla JC, Atasoy D, Avila J, Badawi A, Bading H, Baig AM, Baleriola J, Belmonte C, Bertocchi I, Betz H, Blakemore C, Blanke O, Boehm-Sturm P, Bonhoeffer T, Bonifazi P, Brose N, Campolongo P, Celikel T, Chang CC, Chang TY, Citri A, Cline HT, Cortes JM, Cullen K, Dean K, Delgado-Garcia JM, Desroches M, Disterhoft JF, Dowling JE, Draguhn A, El-Khamisy SF, El Manira A, Enam SA, Encinas JM, Erramuzpe A, Esteban JA, Fariñas I, Fischer E, Fukunaga I, Gabilondo I, Ganten D, Gidon A, Gomez-Esteban JC, Greengard P, Grinevich V, Gruart A, Guillemin R, Hariri AR, Hassan B, Häusser M, Hayashi Y, Hussain NK, Jabbar AA, Jaber M, Jahn R, Janahi EM, Kabbaj M, Kettenmann H, Kindt M, Knafo S, Köhr G, Komai S, Krugers H, Kuhn B, Ghazal NL, Larkum ME, London M, Lutz B, Matute C, Martinez-Millan L, Maroun M, McGaugh J, Moustafa AA, Nasim A, Nave KA, Neher E, Nikolich K, Outeiro T, Palmer LM, Penagarikano O, Perez-Otano I, Pfaff DW, Poucet B, Rahman AU, Ramos-Cabrer P, Rashidy-Pour A, Roberts RJ, Rodrigues S, Sanes JR, Schaefer AT, Segal M, Segev I, Shafqat S, Siddiqui NA, Soreq H, Soriano-García E, Spanagel R, Sprengel R, Stuart G, Südhof TC, Tønnesen J, Treviño M, Uthman BM, Venter JC, Verkhratsky A, Weiss C, Wiesel TN, Yaksi E, Yizhar O, Young LJ, Young P, Zawia NH, Zugaza JL, Hasan MT.

Neuron. 2017 Nov 15;96(4):730-735. doi: 10.1016/j.neuron.2017.09.028.

PMID:
29144972
8.

Differential Molecular Targets for Neuroprotective Effect of Chlorogenic Acid and its Related Compounds Against Glutamate Induced Excitotoxicity and Oxidative Stress in Rat Cortical Neurons.

Rebai O, Belkhir M, Sanchez-Gomez MV, Matute C, Fattouch S, Amri M.

Neurochem Res. 2017 Dec;42(12):3559-3572. doi: 10.1007/s11064-017-2403-9. Epub 2017 Sep 25.

PMID:
28948515
9.

Effects of FTY720 on brain neurogenic niches in vitro and after kainic acid-induced injury.

Cipriani R, Chara JC, Rodríguez-Antigüedad A, Matute C.

J Neuroinflammation. 2017 Jul 24;14(1):147. doi: 10.1186/s12974-017-0922-6.

10.

Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation.

Akwa Y, Gondard E, Mann A, Capetillo-Zarate E, Alberdi E, Matute C, Marty S, Vaccari T, Lozano AM, Baulieu EE, Tampellini D.

Mol Psychiatry. 2017 Jul 11. doi: 10.1038/mp.2017.142. [Epub ahead of print]

11.

Blockade and knock-out of CALHM1 channels attenuate ischemic brain damage.

Cisneros-Mejorado A, Gottlieb M, Ruiz A, Chara JC, Pérez-Samartín A, Marambaud P, Matute C.

J Cereb Blood Flow Metab. 2017 Jan 1:271678X17713587. doi: 10.1177/0271678X17713587. [Epub ahead of print]

PMID:
28597712
12.

In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains.

Cavaliere F, Cerf L, Dehay B, Ramos-Gonzalez P, De Giorgi F, Bourdenx M, Bessede A, Obeso JA, Matute C, Ichas F, Bezard E.

Neurobiol Dis. 2017 Jul;103:101-112. doi: 10.1016/j.nbd.2017.04.011. Epub 2017 Apr 11.

PMID:
28411117
13.

Inwardly Rectifying K+ Currents in Cultured Oligodendrocytes from Rat Optic Nerve are Insensitive to pH.

Pérez-Samartín A, Garay E, Moctezuma JPH, Cisneros-Mejorado A, Sánchez-Gómez MV, Martel-Gallegos G, Robles-Martínez L, Canedo-Antelo M, Matute C, Arellano RO.

Neurochem Res. 2017 Sep;42(9):2443-2455. doi: 10.1007/s11064-017-2242-8. Epub 2017 Mar 27.

PMID:
28345117
14.

GAT-1 mediated GABA uptake in rat oligodendrocytes.

Fattorini G, Melone M, Sánchez-Gómez MV, Arellano RO, Bassi S, Matute C, Conti F.

Glia. 2017 Mar;65(3):514-522. doi: 10.1002/glia.23108. Epub 2017 Jan 10.

PMID:
28071826
15.

Amyloid β-induced astrogliosis is mediated by β1-integrin via NADPH oxidase 2 in Alzheimer's disease.

Wyssenbach A, Quintela T, Llavero F, Zugaza JL, Matute C, Alberdi E.

Aging Cell. 2016 Oct 5. doi: 10.1111/acel.12521. [Epub ahead of print]

16.

Correction: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling.

Abiega O, Beccari S, Diaz-Aparicio I, Nadjar A, Layé S, Leyrolle Q, Gómez-Nicola D, Domercq M, Pérez-Samartín A, Sánchez-Zafra V, Paris I, Valero J, Savage JC, Hui CW, Tremblay MÈ, Deudero JJ, Brewster AL, Anderson AE, Zaldumbide L, Galbarriatu L, Marinas A, Vivanco MD, Matute C, Maletic-Savatic M, Encinas JM, Sierra A.

PLoS Biol. 2016 Sep 20;14(9):e1002554. doi: 10.1371/journal.pbio.1002554. eCollection 2016 Sep.

17.

Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model.

Gomis-González M, Busquets-Garcia A, Matute C, Maldonado R, Mato S, Ozaita A.

Genes (Basel). 2016 Aug 31;7(9). pii: E56. doi: 10.3390/genes7090056.

18.

PET Imaging with [(18)F]FSPG Evidences the Role of System xc(-) on Brain Inflammation Following Cerebral Ischemia in Rats.

Domercq M, Szczupak B, Gejo J, Gómez-Vallejo V, Padro D, Gona KB, Dollé F, Higuchi M, Matute C, Llop J, Martín A.

Theranostics. 2016 Jul 9;6(11):1753-67. doi: 10.7150/thno.15616. eCollection 2016.

19.

Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome.

Borralleras C, Mato S, Amédée T, Matute C, Mulle C, Pérez-Jurado LA, Campuzano V.

Mol Brain. 2016 Aug 2;9(1):76. doi: 10.1186/s13041-016-0258-7.

20.

Correction: Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling.

Abiega O, Beccari S, Diaz-Aparicio I, Nadjar A, Layé S, Leyrolle Q, Gómez-Nicola D, Domercq M, Pérez-Samartín A, Sánchez-Zafra V, Paris I, Valero J, Savage JC, Hui CW, Tremblay MÈ, Deudero JJ, Brewster AL, Anderson AE, Zaldumbide L, Galbarriatu L, Marinas A, Vivanco MD, Matute C, Maletic-Savatic M, Encinas JM, Sierra A.

PLoS Biol. 2016 Jun 30;14(6):e1002508. doi: 10.1371/journal.pbio.1002508. eCollection 2016 Jun.

21.

Adenosine A1 receptor inhibits postnatal neurogenesis and sustains astrogliogenesis from the subventricular zone.

Benito-Muñoz M, Matute C, Cavaliere F.

Glia. 2016 Sep;64(9):1465-78. doi: 10.1002/glia.23010. Epub 2016 Jun 15.

PMID:
27301342
22.

Stroke in young adults: Incidence rate, risk factors, treatment and prognosis.

González-Gómez FJ, Pérez-Torre P, DeFelipe A, Vera R, Matute C, Cruz-Culebras A, Álvarez-Velasco R, Masjuan J.

Rev Clin Esp. 2016 Oct;216(7):345-351. doi: 10.1016/j.rce.2016.05.008. Epub 2016 Jun 11. English, Spanish.

PMID:
27297118
23.

Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism.

Saab AS, Tzvetavona ID, Trevisiol A, Baltan S, Dibaj P, Kusch K, Möbius W, Goetze B, Jahn HM, Huang W, Steffens H, Schomburg ED, Pérez-Samartín A, Pérez-Cerdá F, Bakhtiari D, Matute C, Löwel S, Griesinger C, Hirrlinger J, Kirchhoff F, Nave KA.

Neuron. 2016 Jul 6;91(1):119-32. doi: 10.1016/j.neuron.2016.05.016. Epub 2016 Jun 9.

24.

Cystine/glutamate antiporter blockage induces myelin degeneration.

Soria FN, Zabala A, Pampliega O, Palomino A, Miguelez C, Ugedo L, Sato H, Matute C, Domercq M.

Glia. 2016 Aug;64(8):1381-95. doi: 10.1002/glia.23011. Epub 2016 Jun 1.

PMID:
27247047
25.

Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling.

Abiega O, Beccari S, Diaz-Aparicio I, Nadjar A, Layé S, Leyrolle Q, Gómez-Nicola D, Domercq M, Pérez-Samartín A, Sánchez-Zafra V, Paris I, Valero J, Savage JC, Hui CW, Tremblay MÈ, Deudero JJ, Brewster AL, Anderson AE, Zaldumbide L, Galbarriatu L, Marinas A, Vivanco Md, Matute C, Maletic-Savatic M, Encinas JM, Sierra A.

PLoS Biol. 2016 May 26;14(5):e1002466. doi: 10.1371/journal.pbio.1002466. eCollection 2016 May. Erratum in: PLoS Biol. 2016 Jun;14(6):e1002508. PLoS Biol. 2016 Sep;14(9):e1002554.

26.

Organotypic Cultures as a Model to Study Adult Neurogenesis in CNS Disorders.

Cavaliere F, Benito-Muñoz M, Matute C.

Stem Cells Int. 2016;2016:3540568. doi: 10.1155/2016/3540568. Epub 2016 Apr 5. Review.

27.

In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.

Martín A, Vázquez-Villoldo N, Gómez-Vallejo V, Padro D, Soria FN, Szczupak B, Plaza-García S, Arrieta A, Reese T, Llop J, Domercq M, Matute C.

Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1124-38. doi: 10.1007/s00259-015-3275-3. Epub 2015 Dec 10.

PMID:
26659901
28.

Axon-to-Glia Interaction Regulates GABAA Receptor Expression in Oligodendrocytes.

Arellano RO, Sánchez-Gómez MV, Alberdi E, Canedo-Antelo M, Chara JC, Palomino A, Pérez-Samartín A, Matute C.

Mol Pharmacol. 2016 Jan;89(1):63-74. doi: 10.1124/mol.115.100594. Epub 2015 Nov 4.

29.

Pío del Río Hortega and the discovery of the oligodendrocytes.

Pérez-Cerdá F, Sánchez-Gómez MV, Matute C.

Front Neuroanat. 2015 Jul 7;9:92. doi: 10.3389/fnana.2015.00092. eCollection 2015. Review.

30.

A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.

Gu BJ, Field J, Dutertre S, Ou A, Kilpatrick TJ, Lechner-Scott J, Scott R, Lea R, Taylor BV, Stankovich J, Butzkueven H, Gresle M, Laws SM, Petrou S, Hoffjan S, Akkad DA, Graham CA, Hawkins S, Glaser A, Bedri SK, Hillert J, Matute C, Antiguedad A; ANZgene Consortium, Wiley JS.

Hum Mol Genet. 2015 Oct 1;24(19):5644-54. doi: 10.1093/hmg/ddv278. Epub 2015 Jul 17.

PMID:
26188005
31.

BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year.

Martinez-Cengotitabengoa M, MacDowell KS, Alberich S, Diaz FJ, Garcia-Bueno B, Rodriguez-Jimenez R, Bioque M, Berrocoso E, Parellada M, Lobo A, Saiz PA, Matute C, Bernardo M, Gonzalez-Pinto A, Leza JC; FLAMM-PEPs.

Schizophr Bull. 2016 Jan;42(1):142-51. doi: 10.1093/schbul/sbv078. Epub 2015 Jun 30.

32.

FTY720 attenuates excitotoxicity and neuroinflammation.

Cipriani R, Chara JC, Rodríguez-Antigüedad A, Matute C.

J Neuroinflammation. 2015 May 8;12:86. doi: 10.1186/s12974-015-0308-6.

33.

In vivo PET imaging of the α4β2 nicotinic acetylcholine receptor as a marker for brain inflammation after cerebral ischemia.

Martín A, Szczupak B, Gómez-Vallejo V, Domercq M, Cano A, Padro D, Muñoz C, Higuchi M, Matute C, Llop J.

J Neurosci. 2015 Apr 15;35(15):5998-6009. doi: 10.1523/JNEUROSCI.3670-14.2015.

34.

Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.

González-Ortega I, Alberich S, Echeburúa E, Aizpuru F, Millán E, Vieta E, Matute C, González-Pinto A.

PLoS One. 2015 Apr 15;10(4):e0123707. doi: 10.1371/journal.pone.0123707. eCollection 2015.

35.

Blockade of P2X7 receptors or pannexin-1 channels similarly attenuates postischemic damage.

Cisneros-Mejorado A, Gottlieb M, Cavaliere F, Magnus T, Koch-Nolte F, Scemes E, Pérez-Samartín A, Matute C.

J Cereb Blood Flow Metab. 2015 May;35(5):843-50. doi: 10.1038/jcbfm.2014.262. Epub 2015 Jan 21.

36.

Novel association of Neuregulin 1 gene with bipolar disorder but not with schizophrenia.

Gutiérrez-Fernández A, Palomino A, González-Pinto A, Ugarte A, Hernanz M, Mendíbil B, Etxebeste M, Pacheco L, Gónzalez-García G, Matute C.

Schizophr Res. 2014 Nov;159(2-3):552-3. doi: 10.1016/j.schres.2014.09.001. Epub 2014 Sep 20. No abstract available.

PMID:
25244971
37.

Editors' preface: the colourful white matter.

Matute C, Stys PK.

Glia. 2014 Nov;62(11):1747-8. doi: 10.1002/glia.22747. No abstract available.

PMID:
25212954
38.

Dabigatran in secondary stroke prevention: clinical experience with 106 patients.

DeFelipe-Mimbrera A, Alonso Cánovas A, Guillán M, Matute C, Sainz de la Maza S, Cruz A, Vera R, Masjuan J.

Biomed Res Int. 2014;2014:567026. doi: 10.1155/2014/567026. Epub 2014 Jul 15.

39.

Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo.

Bernal-Chico A, Canedo M, Manterola A, Victoria Sánchez-Gómez M, Pérez-Samartín A, Rodríguez-Puertas R, Matute C, Mato S.

Glia. 2015 Jan;63(1):163-76. doi: 10.1002/glia.22742. Epub 2014 Aug 8.

PMID:
25130621
40.

ATP signaling in brain: release, excitotoxicity and potential therapeutic targets.

Cisneros-Mejorado A, Pérez-Samartín A, Gottlieb M, Matute C.

Cell Mol Neurobiol. 2015 Jan;35(1):1-6. doi: 10.1007/s10571-014-0092-3. Epub 2014 Aug 6. Review.

PMID:
25096398
41.

White matter injury: Ischemic and nonischemic.

Fern RF, Matute C, Stys PK.

Glia. 2014 Nov;62(11):1780-9. doi: 10.1002/glia.22722. Epub 2014 Jul 18. Review.

PMID:
25043122
42.

Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage.

Soria FN, Pérez-Samartín A, Martin A, Gona KB, Llop J, Szczupak B, Chara JC, Matute C, Domercq M.

J Clin Invest. 2014 Aug;124(8):3645-55. doi: 10.1172/JCI71886. Epub 2014 Jul 18.

43.

Neurotransmitter signaling in white matter.

Butt AM, Fern RF, Matute C.

Glia. 2014 Nov;62(11):1762-79. doi: 10.1002/glia.22674. Epub 2014 Apr 21. Review.

PMID:
24753049
44.
45.

Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.

Moreno B, Lopez I, Fernández-Díez B, Gottlieb M, Matute C, Sánchez-Gómez MV, Domercq M, Giralt A, Alberch J, Collon KW, Zhang H, Parent JM, Teixido M, Giralt E, Ceña V, Posadas I, Martínez-Pinilla E, Villoslada P, Franco R.

PLoS One. 2014 Mar 5;9(3):e90671. doi: 10.1371/journal.pone.0090671. eCollection 2014.

46.

NMDA modulates oligodendrocyte differentiation of subventricular zone cells through PKC activation.

Cavaliere F, Benito-Muñoz M, Panicker M, Matute C.

Front Cell Neurosci. 2013 Dec 18;7:261. doi: 10.3389/fncel.2013.00261. eCollection 2013.

47.

A3 Adenosine receptors mediate oligodendrocyte death and ischemic damage to optic nerve.

González-Fernández E, Sánchez-Gómez MV, Pérez-Samartín A, Arellano RO, Matute C.

Glia. 2014 Feb;62(2):199-216. doi: 10.1002/glia.22599. Epub 2013 Dec 6.

PMID:
24311446
48.

P2X4 receptors control the fate and survival of activated microglia.

Vázquez-Villoldo N, Domercq M, Martín A, Llop J, Gómez-Vallejo V, Matute C.

Glia. 2014 Feb;62(2):171-84. doi: 10.1002/glia.22596. Epub 2013 Nov 19.

PMID:
24254916
49.

Contribution of pannexin1 to experimental autoimmune encephalomyelitis.

Lutz SE, González-Fernández E, Ventura JC, Pérez-Samartín A, Tarassishin L, Negoro H, Patel NK, Suadicani SO, Lee SC, Matute C, Scemes E.

PLoS One. 2013 Jun 20;8(6):e66657. doi: 10.1371/journal.pone.0066657. Print 2013.

50.

Neurotransmitter signaling in the pathophysiology of microglia.

Domercq M, Vázquez-Villoldo N, Matute C.

Front Cell Neurosci. 2013 Apr 19;7:49. doi: 10.3389/fncel.2013.00049. eCollection 2013. Erratum in: Front Cell Neurosci. 2013;7:107.

Supplemental Content

Loading ...
Support Center